METFORMIN ER 750 MG

METFORMIN ER 750 MG was reported 303369 times

METFORMIN ER 750 MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LACTIC ACIDOSIS 13095 0.4039
1 NEUROLOGIC NEGLECT SYNDROME 213 0.3831
2 EUGLYCAEMIC DIABETIC KETOACIDOSIS 1461 0.3535
3 PULMONARY VASCULITIS 178 0.3309
4 DIABETIC METABOLIC DECOMPENSATION 371 0.2671
5 CAROTID ARTERY THROMBOSIS 215 0.2532
6 HYPERLACTACIDAEMIA 649 0.2418
7 CATARRH 180 0.1991
8 GASTROINTESTINAL HYPOMOTILITY 398 0.1764
9 ADJUSTMENT DISORDER 226 0.1738
10 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 198 0.1653
11 GLYCOSYLATED HAEMOGLOBIN INCREASED 4117 0.1630
12 ANION GAP INCREASED 213 0.1592
13 KETOACIDOSIS 1180 0.1575
14 METABOLIC ACIDOSIS 4903 0.1532
15 DIABETIC KETOACIDOSIS 3618 0.1505
16 GLYCOSYLATED HAEMOGLOBIN DECREASED 226 0.1403
17 DIABETES MELLITUS INADEQUATE CONTROL 2427 0.1369
18 IMPAIRED GASTRIC EMPTYING 1801 0.1320
19 VITAMIN B12 DEFICIENCY 500 0.1234
20 SUSPECTED SUICIDE 578 0.1232
21 PRODUCT MONITORING ERROR 178 0.1232
22 BLADDER TRANSITIONAL CELL CARCINOMA 174 0.1214
23 HYPOGLYCAEMIA 5824 0.1200
24 DIABETIC NEUROPATHY 586 0.1182
25 NEURITIS 182 0.1178
26 BLOOD BICARBONATE DECREASED 216 0.1140
27 BLOOD LACTIC ACID INCREASED 593 0.1125
28 BLOOD PRESSURE DIASTOLIC ABNORMAL 284 0.1115
29 HYPERPARATHYROIDISM SECONDARY 277 0.1104
30 NEPHROGENIC ANAEMIA 503 0.1085
31 HYPOGLYCAEMIC COMA 308 0.1068
32 BURNS SECOND DEGREE 181 0.1031
33 DISTRIBUTIVE SHOCK 232 0.1023
34 BLOOD GLUCOSE ABNORMAL 1851 0.1001
35 BLOOD GLUCOSE FLUCTUATION 1092 0.0995
36 INSULIN RESISTANCE 207 0.0994
37 DIABETIC RETINOPATHY 332 0.0976
38 PERSONALITY DISORDER 255 0.0973
39 FORCED EXPIRATORY VOLUME DECREASED 271 0.0956
40 ACUTE KIDNEY INJURY 14487 0.0946
41 BLOOD PRESSURE SYSTOLIC ABNORMAL 230 0.0930
42 HYPERKALAEMIA 3198 0.0911
43 INJECTION SITE NODULE 1001 0.0909
44 BLOOD GLUCOSE INCREASED 17094 0.0906
45 PANCREATIC CARCINOMA METASTATIC 249 0.0875
46 DRUG LEVEL ABOVE THERAPEUTIC 396 0.0864
47 IMMUNE-MEDIATED MYOSITIS 237 0.0859
48 BLOOD GLUCOSE DECREASED 4121 0.0857
49 REBOUND ACID HYPERSECRETION 259 0.0855
50 HYPERGLYCAEMIA 3009 0.0825
51 HYPOVOLAEMIA 480 0.0820
52 PEMPHIGOID 603 0.0798
53 ANURIA 658 0.0764
54 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 172 0.0746
55 POTENTIATING DRUG INTERACTION 249 0.0741
56 DIABETIC FOOT 224 0.0731
57 INTENTIONAL DEVICE MISUSE 321 0.0727
58 RESPIRATORY SYMPTOM 205 0.0720
59 NORMOCHROMIC NORMOCYTIC ANAEMIA 213 0.0708
60 HYPOMAGNESAEMIA 986 0.0707
61 ACIDOSIS 533 0.0697
62 SHOCK 1496 0.0650
63 HYPOPNOEA 222 0.0639
64 BLOOD PRESSURE DIASTOLIC DECREASED 472 0.0639
65 ABNORMAL LOSS OF WEIGHT 431 0.0632
66 BLOOD PRESSURE SYSTOLIC INCREASED 1226 0.0628
67 VITAMIN B12 DECREASED 179 0.0620
68 HYPOVOLAEMIC SHOCK 289 0.0603
69 PANCREATITIS ACUTE 1337 0.0594
70 NECROTISING FASCIITIS 208 0.0589
71 GANGRENE 355 0.0589
72 DRUG LEVEL INCREASED 962 0.0581
73 ARTERIOSCLEROSIS CORONARY ARTERY 384 0.0579
74 TYPE 2 DIABETES MELLITUS 1933 0.0574
75 POLYURIA 463 0.0565
76 PSYCHOLOGICAL TRAUMA 488 0.0565
77 DIABETES MELLITUS 4240 0.0556
78 RALES 322 0.0554
79 HAIR DISORDER 455 0.0552
80 INJECTION SITE EXTRAVASATION 679 0.0550
81 DYSLIPIDAEMIA 279 0.0549
82 HYPOTHERMIA 553 0.0546
83 POLYDIPSIA 215 0.0543
84 BODY TEMPERATURE DECREASED 530 0.0538
85 CHRONIC KIDNEY DISEASE 4057 0.0533
86 RENAL TUBULAR NECROSIS 512 0.0521
87 TOE AMPUTATION 264 0.0519
88 LEFT VENTRICULAR HYPERTROPHY 221 0.0516
89 OBSTRUCTIVE AIRWAYS DISORDER 573 0.0515
90 GLOMERULAR FILTRATION RATE DECREASED 632 0.0514
91 SENSORY LOSS 414 0.0514
92 HEPATIC STEATOSIS 957 0.0513
93 END STAGE RENAL DISEASE 934 0.0512
94 BRONCHIECTASIS 345 0.0512
95 RED CELL DISTRIBUTION WIDTH INCREASED 206 0.0495
96 HEMIPLEGIA 411 0.0494
97 HAEMODYNAMIC INSTABILITY 376 0.0493
98 PULSELESS ELECTRICAL ACTIVITY 205 0.0490
99 OVERWEIGHT 259 0.0482
100 LIPASE INCREASED 368 0.0480
101 ERUCTATION 928 0.0479
102 FULL BLOOD COUNT ABNORMAL 504 0.0476
103 OLIGURIA 295 0.0475
104 ARTERIAL OCCLUSIVE DISEASE 372 0.0473
105 NEUROLOGICAL SYMPTOM 270 0.0472
106 HAEMORRHAGIC ANAEMIA 207 0.0470
107 INJECTION SITE MASS 1727 0.0467
108 PANCREATITIS 2452 0.0463
109 BLOOD MAGNESIUM DECREASED 398 0.0461
110 LEFT VENTRICULAR DYSFUNCTION 308 0.0459
111 TUBULOINTERSTITIAL NEPHRITIS 860 0.0458
112 CARDIAC FAILURE CHRONIC 194 0.0455
113 HAIR COLOUR CHANGES 564 0.0453
114 UROSEPSIS 418 0.0453
115 BUNDLE BRANCH BLOCK LEFT 189 0.0445
116 RHINITIS 354 0.0439
117 ARTERIOSCLEROSIS 411 0.0436
118 PAROSMIA 328 0.0434
119 GLUCOSE TOLERANCE IMPAIRED 254 0.0429
120 ACCIDENTAL UNDERDOSE 618 0.0429
121 OBESITY 682 0.0428
122 BLOOD CHOLESTEROL ABNORMAL 197 0.0426
123 EXERCISE TOLERANCE DECREASED 243 0.0422
124 MYOPATHY 362 0.0419
125 ATRIOVENTRICULAR BLOCK FIRST DEGREE 181 0.0417
126 BLOOD PRESSURE DIASTOLIC INCREASED 192 0.0416
127 TACHYPNOEA 537 0.0395
128 WEIGHT DECREASED 11012 0.0394
129 IRON DEFICIENCY 177 0.0393
130 CARDIAC MURMUR 340 0.0393
131 POLYP 255 0.0389
132 LEUKOCYTOSIS 704 0.0389
133 HAIR TEXTURE ABNORMAL 520 0.0388
134 BLOOD TRIGLYCERIDES INCREASED 685 0.0387
135 BREATH SOUNDS ABNORMAL 191 0.0387
136 RENAL FAILURE 5113 0.0385
137 SLEEP APNOEA SYNDROME 731 0.0383
138 ACUTE CORONARY SYNDROME 317 0.0382
139 ANAL INCONTINENCE 344 0.0382
140 ELECTROCARDIOGRAM ABNORMAL 298 0.0379
141 MADAROSIS 437 0.0376
142 THIRST 668 0.0373
143 FLANK PAIN 348 0.0371
144 DEHYDRATION 4950 0.0371
145 RENAL CYST 294 0.0370
146 PULMONARY ALVEOLAR HAEMORRHAGE 207 0.0369
147 CORONARY ARTERY OCCLUSION 506 0.0369
148 MOTOR DYSFUNCTION 376 0.0369
149 ACUTE MYOCARDIAL INFARCTION 1088 0.0369
150 GINGIVAL PAIN 293 0.0368
151 IMPAIRED QUALITY OF LIFE 527 0.0366
152 CHOLELITHIASIS 1200 0.0366
153 CORONARY ARTERY STENOSIS 184 0.0366
154 PANCREATIC DISORDER 180 0.0365
155 RENAL INJURY 1085 0.0365
156 POLLAKIURIA 1514 0.0363
157 EATING DISORDER 771 0.0362
158 HYPERLIPIDAEMIA 432 0.0361
159 NEPHROPATHY 337 0.0361
160 ATRIOVENTRICULAR BLOCK 279 0.0361
161 BLOOD POTASSIUM INCREASED 586 0.0361
162 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 319 0.0360
163 FOOD CRAVING 189 0.0359
164 NODULE 467 0.0357
165 INTESTINAL ISCHAEMIA 197 0.0357
166 TOXICITY TO VARIOUS AGENTS 6016 0.0356
167 APPETITE DISORDER 236 0.0356
168 CARDIOGENIC SHOCK 509 0.0354
169 CORONARY ARTERY DISEASE 1074 0.0354
170 BLOOD IRON DECREASED 419 0.0353
171 RHABDOMYOLYSIS 1464 0.0351
172 ATRIOVENTRICULAR BLOCK COMPLETE 234 0.0349
173 FUNGAL INFECTION 1161 0.0348
174 INJECTION SITE HAEMORRHAGE 2763 0.0346
175 MULTIPLE ORGAN DYSFUNCTION SYNDROME 979 0.0345
176 SPUTUM DISCOLOURED 326 0.0343
177 HYPOPHAGIA 878 0.0343
178 BLADDER CANCER 2015 0.0342
179 ANGINA PECTORIS 980 0.0342
180 NEUTROPHIL COUNT INCREASED 350 0.0341
181 CIRCULATORY COLLAPSE 581 0.0341
182 BLOOD PRESSURE FLUCTUATION 815 0.0339
183 BODY HEIGHT DECREASED 360 0.0336
184 ELECTROLYTE IMBALANCE 391 0.0336
185 LARGE INTESTINE POLYP 233 0.0336
186 DECREASED APPETITE 7802 0.0336
187 METABOLIC DISORDER 195 0.0335
188 AFFECT LABILITY 323 0.0335
189 HUNGER 467 0.0335
190 GASTROENTERITIS 489 0.0335
191 UPPER GASTROINTESTINAL HAEMORRHAGE 563 0.0334
192 DRUG INTERACTION 5306 0.0334
193 PARKINSONISM 326 0.0334
194 HEPATIC CIRRHOSIS 628 0.0334
195 VASCULITIS 389 0.0334
196 SINUS CONGESTION 451 0.0333
197 BLOOD PRESSURE INADEQUATELY CONTROLLED 200 0.0332
198 IRON DEFICIENCY ANAEMIA 304 0.0329
199 ANGINA UNSTABLE 214 0.0329
200 BLOOD CREATININE INCREASED 2133 0.0326
201 INJECTION SITE INJURY 181 0.0326
202 HYPONATRAEMIA 1831 0.0325
203 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 550 0.0324
204 NEUTROPHILIA 184 0.0323
205 COMPLETED SUICIDE 2688 0.0322
206 RENAL FAILURE ACUTE 1368 0.0322
207 CATARACT 1918 0.0322
208 LOWER GASTROINTESTINAL HAEMORRHAGE 238 0.0322
209 MENISCUS INJURY 197 0.0320
210 OSTEOARTHRITIS 1357 0.0320
211 MITRAL VALVE INCOMPETENCE 361 0.0319
212 BLINDNESS TRANSIENT 235 0.0318
213 NOCTURIA 386 0.0318
214 HYPERTRIGLYCERIDAEMIA 186 0.0317
215 MYOCARDIAL ISCHAEMIA 361 0.0317
216 ORTHOSTATIC HYPOTENSION 551 0.0316
217 ACCIDENTAL OVERDOSE 1157 0.0316
218 FAECES SOFT 230 0.0316
219 HEMIPARESIS 535 0.0316
220 CHOLECYSTITIS 376 0.0315
221 EXOSTOSIS 285 0.0312
222 HYPERKERATOSIS 172 0.0311
223 NERVE COMPRESSION 287 0.0311
224 DUODENAL ULCER 218 0.0309
225 SCIATICA 492 0.0308
226 SKIN ULCER 788 0.0305
227 ACUTE RESPIRATORY FAILURE 585 0.0304
228 COORDINATION ABNORMAL 424 0.0304
229 RENAL IMPAIRMENT 2552 0.0303
230 PULMONARY FIBROSIS 581 0.0303
231 CYSTITIS 964 0.0302
232 DYSPNOEA EXERTIONAL 1138 0.0302
233 LOCALISED INFECTION 729 0.0301
234 BLOOD URINE PRESENT 572 0.0301
235 CARPAL TUNNEL SYNDROME 421 0.0300
236 EYE HAEMORRHAGE 401 0.0300
237 DYSURIA 1104 0.0300
238 ATRIAL FLUTTER 239 0.0299
239 WEIGHT FLUCTUATION 313 0.0299
240 URINE OUTPUT DECREASED 261 0.0298
241 DIARRHOEA 19245 0.0298
242 HAEMATURIA 1020 0.0298
243 HYPOCALCAEMIA 563 0.0297
244 SOPOR 394 0.0297
245 RED BLOOD CELL SEDIMENTATION RATE INCREASED 329 0.0297
246 GOUT 531 0.0296
247 TRICUSPID VALVE INCOMPETENCE 235 0.0295
248 HYPOKINESIA 429 0.0295
249 RENAL PAIN 312 0.0294
250 DYSPEPSIA 2881 0.0293
251 GAIT INABILITY 978 0.0292
252 TROPONIN INCREASED 222 0.0291
253 C-REACTIVE PROTEIN ABNORMAL 187 0.0291
254 DYSARTHRIA 1094 0.0290
255 NEPHROLITHIASIS 1329 0.0289
256 BACK INJURY 315 0.0289
257 GASTROOESOPHAGEAL REFLUX DISEASE 2328 0.0289
258 ATRIAL FIBRILLATION 2815 0.0289
259 BLOOD UREA INCREASED 484 0.0289
260 MELAENA 636 0.0289
261 BRADYCARDIA 1531 0.0288
262 DIVERTICULUM 205 0.0288
263 TASTE DISORDER 584 0.0288
264 CONTRAINDICATED PRODUCT ADMINISTERED 871 0.0287
265 FLATULENCE 1625 0.0286
266 BLOOD CHOLESTEROL INCREASED 1334 0.0286
267 HYPOTENSION 5740 0.0286
268 RESPIRATORY RATE INCREASED 254 0.0286
269 DECREASED ACTIVITY 308 0.0285
270 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 293 0.0285
271 HYPOTHYROIDISM 911 0.0285
272 PHARYNGITIS 353 0.0284
273 VOMITING 13365 0.0284
274 CELLULITIS 1430 0.0283
275 SINUS BRADYCARDIA 274 0.0283
276 BLOOD PRESSURE INCREASED 4317 0.0282
277 C-REACTIVE PROTEIN INCREASED 1025 0.0281
278 PYELONEPHRITIS 244 0.0281
279 ROTATOR CUFF SYNDROME 361 0.0281
280 PRODUCTIVE COUGH 1338 0.0280
281 HYPOKALAEMIA 1292 0.0280
282 HYPERCHOLESTEROLAEMIA 270 0.0279
283 HYPERTENSIVE CRISIS 311 0.0279
284 INTENTIONAL OVERDOSE 1786 0.0278
285 SYNOVITIS 502 0.0278
286 INTERVERTEBRAL DISC DEGENERATION 257 0.0277
287 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1334 0.0277
288 CONCOMITANT DISEASE AGGRAVATED 171 0.0277
289 BURSITIS 335 0.0276
290 OSTEOMYELITIS 499 0.0275
291 URINARY INCONTINENCE 816 0.0275
292 EJECTION FRACTION DECREASED 428 0.0275
293 WHEEZING 1616 0.0272
294 PULMONARY MASS 404 0.0271
295 RESPIRATORY TRACT CONGESTION 430 0.0270
296 INCREASED APPETITE 516 0.0270
297 LIGAMENT SPRAIN 267 0.0270
298 FREQUENT BOWEL MOVEMENTS 729 0.0270
299 VITAMIN D DEFICIENCY 263 0.0269
300 URINARY TRACT INFECTION 4592 0.0269
301 SWOLLEN TONGUE 840 0.0269
302 BLOOD POTASSIUM DECREASED 808 0.0268
303 SINUS DISORDER 531 0.0268
304 INTERVERTEBRAL DISC PROTRUSION 585 0.0267
305 MUSCLE ATROPHY 339 0.0267
306 CARDIAC FAILURE ACUTE 178 0.0267
307 CONFUSIONAL STATE 4318 0.0267
308 DIZZINESS POSTURAL 259 0.0267
309 BLOOD PRESSURE ABNORMAL 531 0.0267
310 FEEDING DISORDER 541 0.0266
311 ARTHRITIS 2098 0.0266
312 TRANSIENT ISCHAEMIC ATTACK 899 0.0266
313 GLAUCOMA 513 0.0266
314 ABDOMINAL PAIN 6189 0.0266
315 CONSTIPATION 5800 0.0266
316 WOUND 743 0.0266
317 MICTURITION URGENCY 303 0.0265
318 BLOOD SODIUM DECREASED 500 0.0265
319 EXTRASYSTOLES 185 0.0265
320 PERIPHERAL SWELLING 4075 0.0264
321 MENTAL STATUS CHANGES 734 0.0264
322 MYOSITIS 237 0.0264
323 DRUG-INDUCED LIVER INJURY 827 0.0263
324 HEART RATE DECREASED 925 0.0263
325 UNRESPONSIVE TO STIMULI 679 0.0263
326 COVID-19 PNEUMONIA 310 0.0262
327 LIMB INJURY 712 0.0262
328 ABDOMINAL DISCOMFORT 4389 0.0261
329 HAEMORRHAGIC STROKE 204 0.0261
330 HYPOPHOSPHATAEMIA 193 0.0261
331 HIATUS HERNIA 337 0.0260
332 ABDOMINAL PAIN UPPER 5358 0.0260
333 PRODUCT PRESCRIBING ERROR 616 0.0258
334 SKIN HAEMORRHAGE 383 0.0258
335 GASTRITIS 679 0.0258
336 DYSSTASIA 753 0.0258
337 SINUS TACHYCARDIA 366 0.0257
338 RECTAL HAEMORRHAGE 1104 0.0257
339 HYPERCALCAEMIA 316 0.0256
340 SUPRAVENTRICULAR TACHYCARDIA 245 0.0256
341 DIVERTICULITIS 708 0.0255
342 ELECTROCARDIOGRAM QT PROLONGED 919 0.0255
343 TOOTH ABSCESS 260 0.0255
344 GASTROINTESTINAL HAEMORRHAGE 2133 0.0255
345 VENTRICULAR TACHYCARDIA 419 0.0253
346 NEEDLE ISSUE 738 0.0253
347 RETINAL DETACHMENT 233 0.0253
348 HEPATOMEGALY 249 0.0253
349 NAUSEA 19980 0.0252
350 OXYGEN SATURATION DECREASED 1418 0.0252
351 CANDIDA INFECTION 426 0.0252
352 VENTRICULAR FIBRILLATION 280 0.0252
353 CARDIOMEGALY 310 0.0252
354 LOWER RESPIRATORY TRACT INFECTION 1146 0.0252
355 SPINAL OSTEOARTHRITIS 221 0.0251
356 MUSCLE SPASTICITY 309 0.0251
357 UNDERDOSE 1834 0.0251
358 PRODUCT ODOUR ABNORMAL 263 0.0251
359 ABDOMINAL DISTENSION 2621 0.0251
360 INABILITY TO AFFORD MEDICATION 249 0.0250
361 MUSCULOSKELETAL CHEST PAIN 388 0.0250
362 LOW DENSITY LIPOPROTEIN INCREASED 194 0.0250
363 SALIVARY HYPERSECRETION 249 0.0249
364 INCONTINENCE 263 0.0249
365 GROIN PAIN 218 0.0248
366 APHASIA 749 0.0248
367 JOINT RANGE OF MOTION DECREASED 332 0.0247
368 URINARY RETENTION 826 0.0247
369 TOOTHACHE 446 0.0246
370 FACIAL PARALYSIS 210 0.0246
371 MEDICATION ERROR 1369 0.0246
372 MUSCULAR WEAKNESS 2799 0.0246
373 MUSCULOSKELETAL PAIN 1289 0.0246
374 RETCHING 524 0.0246
375 TENDERNESS 256 0.0245
376 CARDIAC ARREST 2028 0.0245
377 MALNUTRITION 274 0.0245
378 MASS 342 0.0244
379 HYPERTENSION 5180 0.0244
380 ATELECTASIS 236 0.0244
381 SYNCOPE 2443 0.0244
382 HAEMODIALYSIS 205 0.0244
383 FALL 8108 0.0243
384 BASAL CELL CARCINOMA 380 0.0243
385 VENTRICULAR EXTRASYSTOLES 252 0.0242
386 JOINT INJURY 518 0.0242
387 ISCHAEMIC STROKE 432 0.0242
388 HYDRONEPHROSIS 181 0.0242
389 TOOTH INFECTION 318 0.0241
390 PROSTATIC SPECIFIC ANTIGEN INCREASED 332 0.0241
391 CYST 299 0.0241
392 ASTHENIA 9034 0.0240
393 VITAMIN D DECREASED 205 0.0240
394 FURUNCLE 190 0.0240
395 BLINDNESS UNILATERAL 338 0.0239
396 HAEMATEMESIS 606 0.0239
397 IMPAIRED WORK ABILITY 510 0.0238
398 WEIGHT INCREASED 5333 0.0238
399 KIDNEY INFECTION 467 0.0238
400 VISUAL IMPAIRMENT 2949 0.0238
401 LIP SWELLING 792 0.0238
402 ENCEPHALOPATHY 584 0.0238
403 COAGULOPATHY 396 0.0237
404 INCORRECT PRODUCT STORAGE 312 0.0237
405 INTERNAL HAEMORRHAGE 271 0.0237
406 RENAL DISORDER 1105 0.0237
407 COLD SWEAT 417 0.0236
408 PSORIATIC ARTHROPATHY 960 0.0236
409 WHITE BLOOD CELL COUNT INCREASED 903 0.0235
410 FAECES DISCOLOURED 509 0.0235
411 GASTROINTESTINAL DISORDER 2103 0.0235
412 SUBARACHNOID HAEMORRHAGE 239 0.0234
413 HEART RATE IRREGULAR 530 0.0234
414 ABSCESS 374 0.0234
415 HAEMATOMA 607 0.0234
416 ILEUS 291 0.0234
417 INJECTION SITE DISCOMFORT 246 0.0234
418 BLOOD COUNT ABNORMAL 354 0.0233
419 SEPTIC SHOCK 1015 0.0233
420 PRESYNCOPE 565 0.0232
421 SNEEZING 521 0.0232
422 HEART RATE INCREASED 2300 0.0232
423 PANCREATIC CARCINOMA 670 0.0232
424 BLOOD CREATINE PHOSPHOKINASE INCREASED 667 0.0231
425 HEAD INJURY 733 0.0231
426 CARDIAC FAILURE 1858 0.0231
427 AGEUSIA 576 0.0231
428 MIDDLE INSOMNIA 430 0.0230
429 HYPERHIDROSIS 2965 0.0230
430 SLUGGISHNESS 234 0.0229
431 NERVE INJURY 255 0.0229
432 CARDIAC FAILURE CONGESTIVE 1842 0.0229
433 GENERAL PHYSICAL HEALTH DETERIORATION 2652 0.0229
434 GASTRIC ULCER 435 0.0229
435 INTENTIONAL PRODUCT MISUSE 2003 0.0229
436 ANGIOEDEMA 1011 0.0228
437 BOWEL MOVEMENT IRREGULARITY 175 0.0228
438 EOSINOPHILIA 400 0.0228
439 SPINAL DISORDER 216 0.0228
440 TOOTH FRACTURE 251 0.0227
441 SEPSIS 2539 0.0227
442 HIDRADENITIS 207 0.0227
443 INFLUENZA 2524 0.0226
444 POOR VENOUS ACCESS 234 0.0226
445 PAIN IN EXTREMITY 6662 0.0226
446 RESPIRATORY FAILURE 1646 0.0225
447 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1176 0.0225
448 SPINAL PAIN 264 0.0225
449 RIB FRACTURE 463 0.0225
450 HAEMORRHOIDS 439 0.0225
451 HYPOXIA 792 0.0225
452 OEDEMA PERIPHERAL 2741 0.0225
453 STENT PLACEMENT 181 0.0224
454 PULMONARY OEDEMA 1004 0.0224
455 HICCUPS 184 0.0224
456 PERICARDITIS 376 0.0224
457 PULMONARY CONGESTION 295 0.0224
458 WOUND INFECTION 245 0.0223
459 ANAEMIA 4261 0.0223
460 HAEMATOCRIT DECREASED 443 0.0223
461 FIBROMYALGIA 543 0.0223
462 FACIAL PAIN 199 0.0223
463 BALANCE DISORDER 1924 0.0222
464 TACHYCARDIA 1973 0.0222
465 PRODUCT DOSE OMISSION 1448 0.0222
466 APHTHOUS ULCER 172 0.0222
467 POOR QUALITY SLEEP 476 0.0221
468 DRUG DOSE OMISSION 3642 0.0220
469 PERIPHERAL COLDNESS 302 0.0220
470 ASTHMA 2484 0.0220
471 DRY MOUTH 1783 0.0220
472 RHINORRHOEA 1419 0.0219
473 METASTASES TO LIVER 385 0.0219
474 BRONCHITIS 1621 0.0219
475 GAIT DISTURBANCE 4185 0.0218
476 INCORRECT DOSE ADMINISTERED BY DEVICE 573 0.0218
477 SPLENOMEGALY 256 0.0218
478 FRUSTRATION TOLERANCE DECREASED 176 0.0218
479 DISORIENTATION 863 0.0218
480 HAEMOPTYSIS 607 0.0217
481 INTENTIONAL PRODUCT USE ISSUE 1906 0.0217
482 IRRITABLE BOWEL SYNDROME 466 0.0217
483 DIZZINESS 10830 0.0217
484 BACK DISORDER 353 0.0217
485 INTERNATIONAL NORMALISED RATIO INCREASED 619 0.0217
486 DYSGEUSIA 1612 0.0217
487 LETHARGY 1245 0.0216
488 ULCER 344 0.0216
489 CHEST PAIN 4004 0.0216
490 INJECTION SITE BRUISING 1724 0.0216
491 BACK PAIN 5013 0.0216
492 ABNORMAL FAECES 176 0.0215
493 LIVER FUNCTION TEST ABNORMAL 624 0.0214
494 GASTROINTESTINAL PAIN 236 0.0214
495 NEUROPATHY PERIPHERAL 2040 0.0214
496 FEELING COLD 597 0.0214
497 SKIN LESION 588 0.0214
498 RED BLOOD CELL COUNT DECREASED 612 0.0214
499 PLATELET COUNT INCREASED 279 0.0214
500 COMA 1019 0.0214
501 SHOCK HAEMORRHAGIC 174 0.0214
502 COUGH 5985 0.0213
503 HAEMATOCHEZIA 1177 0.0213
504 VERTIGO 1299 0.0213
505 HERNIA 412 0.0213
506 SLEEP DISORDER 1501 0.0212
507 CHROMATURIA 479 0.0212
508 BLOOD PRESSURE DECREASED 1409 0.0212
509 SEASONAL ALLERGY 300 0.0212
510 GASTROENTERITIS VIRAL 382 0.0211
511 SCHIZOPHRENIA 256 0.0210
512 SUBDURAL HAEMATOMA 301 0.0210
513 ALTERED STATE OF CONSCIOUSNESS 455 0.0210
514 DEVICE LEAKAGE 909 0.0209
515 MALAISE 9170 0.0209
516 EAR PAIN 406 0.0209
517 LIMB DISCOMFORT 646 0.0209
518 MEMORY IMPAIRMENT 2867 0.0208
519 MOBILITY DECREASED 1498 0.0208
520 DYSPNOEA 11754 0.0207
521 PSORIASIS 2708 0.0207
522 OROPHARYNGEAL PAIN 1919 0.0207
523 CHEST DISCOMFORT 2122 0.0207
524 NECK PAIN 1158 0.0207
525 LOCAL SWELLING 361 0.0207
526 LUNG DISORDER 1013 0.0206
527 HEPATIC ENZYME INCREASED 1407 0.0206
528 CEREBROVASCULAR ACCIDENT 3493 0.0206
529 JOINT SWELLING 2488 0.0206
530 NEURALGIA 500 0.0205
531 PALLOR 558 0.0205
532 CARDIOMYOPATHY 303 0.0205
533 THYROID DISORDER 316 0.0205
534 MALIGNANT MELANOMA 274 0.0204
535 RESPIRATORY DISTRESS 564 0.0204
536 TREATMENT NONCOMPLIANCE 1118 0.0204
537 SKIN LACERATION 222 0.0204
538 GALLBLADDER DISORDER 364 0.0204
539 BLINDNESS 830 0.0203
540 ORAL PAIN 456 0.0203
541 PALPITATIONS 2385 0.0203
542 ARRHYTHMIA 964 0.0203
543 PROTEINURIA 387 0.0203
544 ANKLE FRACTURE 315 0.0203
545 MYOCARDIAL INFARCTION 3549 0.0203
546 GRIP STRENGTH DECREASED 179 0.0203
547 HAEMOGLOBIN DECREASED 2084 0.0203
548 DEPRESSED LEVEL OF CONSCIOUSNESS 802 0.0203
549 IMPAIRED HEALING 665 0.0202
550 JAUNDICE 545 0.0202
551 DELIRIUM 702 0.0202
552 EMPHYSEMA 204 0.0202
553 MYALGIA 3432 0.0202
554 METASTASES TO LUNG 233 0.0201
555 MUSCULOSKELETAL DISCOMFORT 347 0.0201
556 VITREOUS FLOATERS 198 0.0201
557 GAMMA-GLUTAMYLTRANSFERASE INCREASED 446 0.0201
558 HEPATIC CYTOLYSIS 256 0.0201
559 MYOCARDITIS 230 0.0200
560 SECRETION DISCHARGE 251 0.0200
561 HEPATIC ENCEPHALOPATHY 187 0.0200
562 ARTHROPATHY 1113 0.0200
563 VISION BLURRED 2748 0.0200
564 LOSS OF CONSCIOUSNESS 2563 0.0200
565 ASPIRATION 219 0.0200
566 BLOOD THYROID STIMULATING HORMONE INCREASED 184 0.0200
567 EYE DISORDER 657 0.0200
568 PULMONARY EMBOLISM 1897 0.0199
569 ACUTE HEPATIC FAILURE 272 0.0199
570 BLISTER 1117 0.0199
571 FEELING JITTERY 379 0.0199
572 PRURITUS GENERALISED 430 0.0199
573 INJECTION SITE PAIN 6097 0.0199
574 INJECTION SITE PRURITUS 1329 0.0198
575 MUSCLE SPASMS 3640 0.0198
576 ORAL CANDIDIASIS 261 0.0198
577 NEPHROPATHY TOXIC 222 0.0198
578 HYPERTHYROIDISM 286 0.0197
579 TENDONITIS 305 0.0197
580 OESOPHAGITIS 215 0.0197
581 LIVER FUNCTION TEST INCREASED 422 0.0196
582 GASTROINTESTINAL INFECTION 176 0.0196
583 SUICIDE ATTEMPT 1190 0.0196
584 PNEUMONIA 6352 0.0196
585 FATIGUE 15270 0.0196
586 SKIN INFECTION 220 0.0196
587 INTESTINAL OBSTRUCTION 739 0.0196
588 INITIAL INSOMNIA 201 0.0196
589 NASAL CONGESTION 1149 0.0195
590 NIGHTMARE 676 0.0195
591 NASOPHARYNGITIS 3596 0.0195
592 SOMNOLENCE 3927 0.0195
593 NEOPLASM 224 0.0195
594 TRANSFUSION 204 0.0195
595 DYSPHONIA 1137 0.0194
596 FLUID RETENTION 988 0.0194
597 SMALL INTESTINAL OBSTRUCTION 239 0.0194
598 HYPERSOMNIA 555 0.0193
599 NIGHT SWEATS 622 0.0193
600 HOT FLUSH 1449 0.0192
601 EXTRA DOSE ADMINISTERED 778 0.0192
602 PERICARDIAL EFFUSION 444 0.0192
603 FOOT FRACTURE 364 0.0192
604 DIPLOPIA 498 0.0192
605 SINUSITIS 1965 0.0192
606 RASH PRURITIC 1036 0.0191
607 TREMOR 3165 0.0190
608 APHONIA 266 0.0190
609 EAR INFECTION 506 0.0190
610 ERECTILE DYSFUNCTION 488 0.0190
611 DISCOMFORT 1159 0.0190
612 POISONING DELIBERATE 180 0.0190
613 DEPRESSED MOOD 1003 0.0190
614 PREMATURE DELIVERY 302 0.0189
615 HALLUCINATION, VISUAL 400 0.0189
616 SKIN DISCOLOURATION 870 0.0189
617 GENERALISED OEDEMA 234 0.0189
618 SWELLING FACE 1228 0.0188
619 MENTAL IMPAIRMENT 457 0.0188
620 SCAB 215 0.0188
621 ARTHRALGIA 7825 0.0188
622 PULMONARY HYPERTENSION 392 0.0188
623 CHOKING 367 0.0188
624 NERVOUSNESS 981 0.0188
625 HALLUCINATION, AUDITORY 298 0.0187
626 MOVEMENT DISORDER 602 0.0187
627 SENSORY DISTURBANCE 300 0.0187
628 DYSPHAGIA 1774 0.0187
629 FEELING HOT 1145 0.0187
630 SUDDEN DEATH 197 0.0186
631 CONTUSION 1791 0.0186
632 PRODUCT ADMINISTRATION ERROR 375 0.0185
633 SARS-COV-2 TEST POSITIVE 245 0.0185
634 ADRENAL INSUFFICIENCY 225 0.0185
635 TINNITUS 850 0.0185
636 DRY THROAT 188 0.0185
637 HYPOAESTHESIA 2767 0.0185
638 MUSCLE RIGIDITY 221 0.0185
639 PNEUMONIA ASPIRATION 461 0.0184
640 SCRATCH 194 0.0184
641 ABDOMINAL PAIN LOWER 465 0.0184
642 ALANINE AMINOTRANSFERASE INCREASED 1129 0.0184
643 POLYNEUROPATHY 220 0.0184
644 RESTLESS LEGS SYNDROME 334 0.0183
645 VISUAL ACUITY REDUCED 610 0.0183
646 INCORRECT DOSE ADMINISTERED 4190 0.0183
647 CARDIAC DISORDER 1717 0.0183
648 BRAIN INJURY 184 0.0183
649 EYE INFECTION 207 0.0183
650 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3298 0.0183
651 CHOLECYSTECTOMY 209 0.0183
652 UPPER LIMB FRACTURE 363 0.0182
653 HEAD DISCOMFORT 322 0.0182
654 HYPOACUSIS 782 0.0181
655 ALOPECIA 3566 0.0181
656 OSTEOPENIA 275 0.0181
657 FEELING ABNORMAL 4335 0.0181
658 DEPRESSION 4113 0.0181
659 UPPER RESPIRATORY TRACT INFECTION 835 0.0181
660 COVID-19 3161 0.0180
661 HEPATIC FAILURE 543 0.0180
662 OSTEOPOROSIS 739 0.0179
663 HEPATOTOXICITY 400 0.0179
664 EPISTAXIS 1343 0.0179
665 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1274 0.0179
666 AMNESIA 1164 0.0179
667 GASTRIC DISORDER 614 0.0179
668 OEDEMA 968 0.0178
669 MUSCLE TIGHTNESS 289 0.0178
670 COGNITIVE DISORDER 833 0.0178
671 DEMENTIA 498 0.0178
672 FOOT DEFORMITY 197 0.0178
673 BLADDER DISORDER 176 0.0177
674 HEPATOCELLULAR INJURY 251 0.0177
675 THERAPY CHANGE 174 0.0177
676 JOINT STIFFNESS 464 0.0177
677 CONDITION AGGRAVATED 5325 0.0175
678 JOINT DISLOCATION 185 0.0175
679 THERAPY CESSATION 898 0.0175
680 BURNING SENSATION 1223 0.0174
681 INSOMNIA 4624 0.0173
682 INFLAMMATION 895 0.0173
683 BLOOD TEST ABNORMAL 243 0.0173
684 CEREBRAL HAEMORRHAGE 619 0.0173
685 ANXIETY 4914 0.0172
686 DEEP VEIN THROMBOSIS 1122 0.0172
687 MACULAR DEGENERATION 206 0.0172
688 CHOLESTASIS 331 0.0172
689 IMMUNODEFICIENCY 256 0.0172
690 PHARYNGEAL OEDEMA 264 0.0171
691 MUSCULOSKELETAL STIFFNESS 1502 0.0171
692 PARAESTHESIA ORAL 247 0.0171
693 PEMPHIGUS 214 0.0171
694 DISTURBANCE IN ATTENTION 923 0.0171
695 RESPIRATORY TRACT INFECTION 445 0.0171
696 BLOOD ALKALINE PHOSPHATASE INCREASED 424 0.0171
697 FOLLICULITIS 178 0.0170
698 GLOSSODYNIA 380 0.0170
699 DRUG PRESCRIBING ERROR 326 0.0170
700 PLEURAL EFFUSION 1029 0.0169
701 CARDIO-RESPIRATORY ARREST 707 0.0169
702 SWELLING 1580 0.0169
703 PARAESTHESIA 2654 0.0169
704 PAIN 10353 0.0168
705 PRESCRIBED UNDERDOSE 336 0.0168
706 BLOOD CALCIUM DECREASED 189 0.0168
707 HEPATITIS 429 0.0167
708 LIVER INJURY 411 0.0167
709 CARDIOVASCULAR DISORDER 425 0.0167
710 BEDRIDDEN 220 0.0167
711 HEADACHE 10494 0.0167
712 COLON CANCER 248 0.0166
713 IMPAIRED DRIVING ABILITY 189 0.0166
714 NEUROLEPTIC MALIGNANT SYNDROME 197 0.0166
715 DRUG INTOLERANCE 1604 0.0166
716 PULMONARY THROMBOSIS 181 0.0166
717 CHILLS 1946 0.0166
718 COLITIS 629 0.0166
719 PRESCRIBED OVERDOSE 320 0.0165
720 HERPES ZOSTER 950 0.0165
721 TENDON RUPTURE 203 0.0164
722 ANOSMIA 238 0.0164
723 DELUSION 255 0.0164
724 GENERALISED TONIC-CLONIC SEIZURE 271 0.0164
725 RHEUMATOID ARTHRITIS 1858 0.0163
726 SPEECH DISORDER 855 0.0163
727 CLOSTRIDIUM DIFFICILE COLITIS 173 0.0163
728 SCAR 279 0.0163
729 ATAXIA 193 0.0162
730 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1155 0.0162
731 INJECTION SITE DISCOLOURATION 202 0.0162
732 DRUG DISPENSING ERROR 247 0.0161
733 FLUSHING 1641 0.0161
734 HIP FRACTURE 518 0.0161
735 MUSCLE TWITCHING 371 0.0161
736 IMMUNE SYSTEM DISORDER 212 0.0161
737 HAEMORRHAGE INTRACRANIAL 240 0.0160
738 EYE SWELLING 596 0.0160
739 ACUTE RESPIRATORY DISTRESS SYNDROME 283 0.0160
740 PANCYTOPENIA 894 0.0160
741 PHOTOSENSITIVITY REACTION 264 0.0160
742 ASPARTATE AMINOTRANSFERASE INCREASED 847 0.0159
743 TRANSAMINASES INCREASED 354 0.0159
744 INJURY ASSOCIATED WITH DEVICE 324 0.0159
745 THROAT IRRITATION 712 0.0159
746 BRAIN FOG 247 0.0157
747 ROAD TRAFFIC ACCIDENT 658 0.0157
748 AGITATION 1155 0.0157
749 PRODUCT QUALITY ISSUE 2134 0.0157
750 LACRIMATION INCREASED 473 0.0156
751 THROMBOSIS 1259 0.0156
752 INFUSION RELATED REACTION 1035 0.0156
753 POISONING 196 0.0156
754 THINKING ABNORMAL 290 0.0155
755 PRURITUS 5979 0.0155
756 DEVICE MALFUNCTION 1093 0.0155
757 PROCEDURAL PAIN 431 0.0155
758 BONE PAIN 909 0.0155
759 ASCITES 455 0.0155
760 HALLUCINATION 1159 0.0154
761 DIALYSIS 218 0.0153
762 THERAPEUTIC PRODUCT EFFECT DECREASED 687 0.0153
763 INTENTIONAL DOSE OMISSION 437 0.0153
764 VIRAL INFECTION 510 0.0153
765 DRUG EFFECT INCOMPLETE 556 0.0153
766 BODY TEMPERATURE INCREASED 312 0.0153
767 PYREXIA 5282 0.0152
768 BONE DISORDER 278 0.0152
769 SEROTONIN SYNDROME 293 0.0152
770 BACTERAEMIA 181 0.0152
771 DEVICE MECHANICAL ISSUE 209 0.0152
772 EXPIRED PRODUCT ADMINISTERED 505 0.0152
773 PARALYSIS 217 0.0151
774 TOOTH DISORDER 337 0.0151
775 INJECTION SITE URTICARIA 371 0.0151
776 EYE PAIN 852 0.0151
777 BLOOD BILIRUBIN INCREASED 407 0.0151
778 PRODUCT USE ISSUE 2831 0.0150
779 HYPOAESTHESIA ORAL 227 0.0150
780 THERAPEUTIC RESPONSE UNEXPECTED 672 0.0150
781 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 699 0.0149
782 INJECTION SITE INDURATION 194 0.0149
783 DISEASE RECURRENCE 708 0.0149
784 ANHEDONIA 391 0.0149
785 RASH MACULO-PAPULAR 331 0.0149
786 KNEE ARTHROPLASTY 313 0.0149
787 APATHY 216 0.0148
788 ILLNESS 1524 0.0148
789 LIVER DISORDER 656 0.0148
790 PAIN IN JAW 419 0.0148
791 FULL BLOOD COUNT DECREASED 298 0.0148
792 INSURANCE ISSUE 226 0.0148
793 RESPIRATORY DISORDER 441 0.0147
794 POST PROCEDURAL COMPLICATION 283 0.0147
795 DRUG ERUPTION 261 0.0147
796 METASTASES TO BONE 241 0.0147
797 ORAL DISCOMFORT 204 0.0147
798 STAPHYLOCOCCAL INFECTION 483 0.0146
799 THROAT TIGHTNESS 396 0.0146
800 LUNG INFECTION 227 0.0146
801 ABASIA 361 0.0146
802 INTRAOCULAR PRESSURE INCREASED 186 0.0145
803 PREMATURE BABY 438 0.0145
804 LOWER LIMB FRACTURE 279 0.0145
805 WRIST FRACTURE 174 0.0145
806 RASH PAPULAR 325 0.0145
807 CEREBRAL INFARCTION 354 0.0145
808 ABNORMAL DREAMS 400 0.0145
809 RASH GENERALISED 375 0.0145
810 RESTLESSNESS 529 0.0144
811 SKIN EXFOLIATION 1218 0.0144
812 LYMPHOCYTE COUNT DECREASED 255 0.0144
813 QUALITY OF LIFE DECREASED 193 0.0144
814 INFECTION 2078 0.0143
815 LYMPHADENOPATHY 508 0.0143
816 DYSKINESIA 583 0.0143
817 PLATELET COUNT DECREASED 1528 0.0143
818 ACCIDENT 171 0.0143
819 RASH MACULAR 499 0.0143
820 MOOD ALTERED 389 0.0142
821 DEVICE ISSUE 1278 0.0142
822 OFF LABEL USE 12393 0.0141
823 SKIN DISORDER 472 0.0141
824 DEAFNESS 370 0.0141
825 PRODUCT TASTE ABNORMAL 191 0.0141
826 URTICARIA 2362 0.0141
827 PRODUCT SUBSTITUTION ISSUE 810 0.0141
828 PNEUMONITIS 383 0.0141
829 BACTERIAL INFECTION 262 0.0140
830 HAND DEFORMITY 184 0.0140
831 MUSCULOSKELETAL DISORDER 267 0.0140
832 RASH 6101 0.0140
833 INCORRECT PRODUCT ADMINISTRATION DURATION 303 0.0140
834 FEBRILE NEUTROPENIA 925 0.0139
835 FACE OEDEMA 235 0.0139
836 SPINAL FRACTURE 279 0.0139
837 COLITIS ULCERATIVE 620 0.0139
838 MUCOSAL INFLAMMATION 363 0.0139
839 FEAR 371 0.0138
840 MIGRAINE 1314 0.0138
841 STOMATITIS 834 0.0137
842 CLOSTRIDIUM DIFFICILE INFECTION 300 0.0137
843 PHOTOPHOBIA 257 0.0137
844 PRODUCT PHYSICAL ISSUE 275 0.0136
845 BRAIN OEDEMA 172 0.0136
846 MENTAL DISORDER 592 0.0136
847 ECONOMIC PROBLEM 206 0.0136
848 INFLUENZA LIKE ILLNESS 1116 0.0135
849 THERAPY INTERRUPTED 960 0.0134
850 FLUID OVERLOAD 195 0.0134
851 FOETAL EXPOSURE DURING PREGNANCY 1088 0.0134
852 OVERDOSE 2877 0.0133
853 PSYCHOTIC DISORDER 393 0.0133
854 DRUG ADMINISTRATION ERROR 407 0.0132
855 DRUG EFFECT DECREASED 714 0.0132
856 ACTIVITIES OF DAILY LIVING IMPAIRED 262 0.0132
857 MULTI-ORGAN FAILURE 227 0.0131
858 EYE PRURITUS 441 0.0131
859 ANAPHYLACTIC REACTION 725 0.0131
860 INJECTION SITE RASH 402 0.0131
861 TREATMENT FAILURE 1085 0.0131
862 SYSTEMIC LUPUS ERYTHEMATOSUS 464 0.0131
863 ADVERSE DRUG REACTION 1168 0.0130
864 SEDATION 340 0.0130
865 PANIC ATTACK 472 0.0129
866 GINGIVAL BLEEDING 175 0.0128
867 ANGER 433 0.0128
868 PAIN OF SKIN 344 0.0128
869 ERYTHEMA 2620 0.0127
870 HYPERSENSITIVITY 2363 0.0127
871 SKIN REACTION 179 0.0127
872 MANIA 209 0.0127
873 PARANOIA 219 0.0127
874 THROMBOCYTOPENIA 1420 0.0127
875 LABORATORY TEST ABNORMAL 374 0.0127
876 IRRITABILITY 758 0.0126
877 MULTIPLE FRACTURES 207 0.0126
878 DRUG INEFFECTIVE 16576 0.0126
879 INJECTION SITE SWELLING 961 0.0125
880 WHITE BLOOD CELL COUNT DECREASED 1347 0.0124
881 INCORRECT DRUG ADMINISTRATION DURATION 348 0.0124
882 MOUTH ULCERATION 260 0.0123
883 SEIZURE 1413 0.0122
884 PRODUCT DOSE OMISSION ISSUE 3577 0.0122
885 FEMUR FRACTURE 376 0.0121
886 SKIN CANCER 261 0.0121
887 RASH ERYTHEMATOUS 579 0.0121
888 INJECTION SITE ERYTHEMA 1500 0.0121
889 CRYING 431 0.0118
890 DEVICE FAILURE 180 0.0118
891 SKIN FISSURES 231 0.0118
892 PRODUCT DISPENSING ERROR 257 0.0118
893 MATERNAL EXPOSURE DURING PREGNANCY 1048 0.0117
894 SUICIDAL IDEATION 1075 0.0117
895 PRODUCT AVAILABILITY ISSUE 267 0.0117
896 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 641 0.0117
897 DRY EYE 583 0.0117
898 CYANOSIS 183 0.0116
899 INTERSTITIAL LUNG DISEASE 563 0.0116
900 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 199 0.0116
901 BLOOD LACTATE DEHYDROGENASE INCREASED 183 0.0115
902 PRODUCT USE IN UNAPPROVED INDICATION 2860 0.0115
903 ECZEMA 602 0.0115
904 HIP ARTHROPLASTY 176 0.0115
905 EYE IRRITATION 661 0.0115
906 EPILEPSY 351 0.0115
907 ABNORMAL BEHAVIOUR 453 0.0114
908 THERAPY NON-RESPONDER 512 0.0114
909 DISEASE PROGRESSION 1340 0.0113
910 WITHDRAWAL SYNDROME 474 0.0113
911 EXPOSURE DURING PREGNANCY 700 0.0113
912 PSYCHOMOTOR HYPERACTIVITY 186 0.0112
913 ILL-DEFINED DISORDER 678 0.0111
914 AGGRESSION 556 0.0111
915 PRODUCT USE COMPLAINT 175 0.0111
916 NEUTROPHIL COUNT DECREASED 452 0.0111
917 DEVICE DELIVERY SYSTEM ISSUE 303 0.0111
918 THERAPEUTIC RESPONSE DECREASED 670 0.0110
919 FRACTURE 208 0.0110
920 INJURY 772 0.0110
921 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2225 0.0110
922 DERMATITIS 230 0.0110
923 MALIGNANT NEOPLASM PROGRESSION 1113 0.0109
924 HAEMORRHAGE 1130 0.0108
925 APPLICATION SITE PAIN 237 0.0107
926 RESPIRATORY ARREST 295 0.0107
927 INJECTION SITE WARMTH 220 0.0107
928 THERAPEUTIC RESPONSE SHORTENED 354 0.0107
929 AGRANULOCYTOSIS 197 0.0106
930 VAGINAL HAEMORRHAGE 460 0.0106
931 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 357 0.0106
932 PRODUCT DOSE OMISSION IN ERROR 299 0.0105
933 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 243 0.0104
934 WRONG TECHNIQUE IN DRUG USAGE PROCESS 378 0.0104
935 SURGERY 610 0.0104
936 ORAL HERPES 203 0.0104
937 PELVIC PAIN 188 0.0103
938 OCULAR HYPERAEMIA 491 0.0103
939 DEVICE DEFECTIVE 179 0.0103
940 NEUTROPENIA 1401 0.0103
941 DRY SKIN 1351 0.0101
942 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 260 0.0101
943 NERVOUS SYSTEM DISORDER 315 0.0101
944 NEOPLASM PROGRESSION 348 0.0100
945 DEVICE USE ISSUE 175 0.0100
946 UNEVALUABLE EVENT 756 0.0100
947 INJECTION SITE REACTION 676 0.0098
948 MOOD SWINGS 312 0.0098
949 TOOTH LOSS 194 0.0093
950 OSTEONECROSIS OF JAW 231 0.0093
951 INTENTIONAL SELF-INJURY 186 0.0092
952 EMOTIONAL DISTRESS 1110 0.0092
953 PLASMA CELL MYELOMA 357 0.0091
954 LEUKOPENIA 453 0.0090
955 ANAPHYLACTIC SHOCK 232 0.0090
956 LUNG NEOPLASM MALIGNANT 368 0.0089
957 EMOTIONAL DISORDER 275 0.0089
958 ADVERSE EVENT 808 0.0088
959 PRODUCT STORAGE ERROR 757 0.0086
960 NEOPLASM MALIGNANT 571 0.0085
961 HOSPITALISATION 1308 0.0085
962 APPLICATION SITE PRURITUS 193 0.0085
963 PRODUCT PRESCRIBING ISSUE 178 0.0082
964 DEATH 6835 0.0079
965 APPLICATION SITE ERYTHEMA 206 0.0079
966 TARDIVE DYSKINESIA 218 0.0077
967 ABORTION SPONTANEOUS 309 0.0077
968 BONE DENSITY DECREASED 237 0.0076
969 DRUG RESISTANCE 194 0.0075
970 PRODUCT ADHESION ISSUE 256 0.0072
971 HEPATIC CANCER 172 0.0071
972 SKIN IRRITATION 316 0.0069
973 HEPATIC FUNCTION ABNORMAL 252 0.0067
974 DRUG ABUSE 536 0.0064
975 MULTIPLE SCLEROSIS 296 0.0062
976 SKIN BURNING SENSATION 437 0.0061
977 BREAST CANCER 553 0.0059
978 ACNE 447 0.0059
979 MULTIPLE SCLEROSIS RELAPSE 400 0.0058
980 DEVICE BREAKAGE 225 0.0055
981 OSTEONECROSIS 182 0.0055
982 PROSTATE CANCER 428 0.0053
983 DEVICE DISLOCATION 222 0.0051
984 CONVULSION 286 0.0050
985 INCORRECT ROUTE OF DRUG ADMINISTRATION 176 0.0049
986 DERMATITIS ATOPIC 252 0.0048
987 ACCIDENTAL EXPOSURE TO PRODUCT 491 0.0048
988 DRUG WITHDRAWAL SYNDROME 410 0.0047
989 DRUG DOSE OMISSION BY DEVICE 342 0.0044
990 NO ADVERSE EVENT 780 0.0043
991 RENAL CANCER 187 0.0039
992 DEVICE DIFFICULT TO USE 181 0.0027
993 DRUG DEPENDENCE 358 0.0022